Skip to main content
AMA Journal of Ethics®
Illuminating the Art of Medicine

Main navigation

  • Issues
  • Articles
  • Cases
  • Art
  • Multimedia
  • CME
  • Topics
  • For Authors
  • Call for Papers
  • Call for Artwork
  • Call for Editorial Fellows
  • Art Collaborations
  • Register for Sep 10 Grand Rounds
  • En Español

Featured Content

Case and Commentary
Apr 2025

¿Cómo deberían proteger los miembros del equipo de cirugía a los pacientes que están privados de libertad de la vigilancia o intrusión de los oficiales del centro penitenciario?

Anna Lin, MD and Mallory Williams, MD, MPH
Case and Commentary
Feb 2025

¿Cómo se debe describir y tratar el dolor causado por la colocación del DIU?

Veronica Hutchison, MD and Eve Espey, MD, MPH

Articles

Article Types
Topics
Core Competencies
Specialties
Language
Reset
  • podcast2-1912
    Policy Forum
    Dec 2019

    Why Include the Public in Genome Editing Governance Deliberation?

    Alessandro Blasimme, PhD
    International debate about human genome editing governance has undergone a paradigm shift and suggests that inclusive public deliberation is still important.
    AMA J Ethics. 2019;21(12):E1065-1070. doi: 10.1001/amajethics.2019.1065.
  • cscm3-1912
    Case and Commentary
    Dec 2019

    How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity?

    Charis Thompson, PhD
    Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation.
    AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
  • cscm1-1911
    Case and Commentary
    Nov 2019

    In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most?

    Andrea DiMartini, MD and Mary Amanda Dew, PhD
    Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research.
    AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
  • msoc4-1911
    Medicine and Society
    Nov 2019

    What Do Unusual Faces Teach Us About the Ethics of Recognition?

    Rosemarie Garland-Thomson, PhD
    Drawing on the film Wonder, this article examines how a narrative of community acceptance offers sustaining relationships for people with unusual facial appearance.
    AMA J Ethics. 2019;21(11):E1003-1008. doi: 10.1001/amajethics.2019.1003.
  • artm1-1911
    Art of Medicine
    Nov 2019

    Representing Communication, Compassion, and Competence in the Era of AI

    Antonio Yaghy, MD, Jerry A. Shields, MD, and Carol L. Shields, MD
    Two digital photo-paintings address AI applications in medicine narratively and visually, with special emphasis on communication, compassion, and competence.
    AMA J Ethics. 2019;21(11):E1009-1013. doi: 10.1001/amajethics.2019.1009.
  • msoc1-peer-1911
    Medicine and Society
    Nov 2019

    How to Integrate Lived Experience Into Quality-of-Life Assessment in Patients Considering Facial Transplantation

    Laura L. Kimberly, MSW, MBE, Allyson R. Alfonso, Elie P. Ramly, MD, Rami S. Kantar, MD, Arthur L. Caplan, PhD, and Eduardo D. Rodriguez, MD, DDS
    Facial transplantation must establish approaches to assessing QoL in candidates and recipients that use meaningful outcomes.
    AMA J Ethics. 2019;21(11):E980-987. doi: 10.1001/amajethics.2019.980.
  • msoc2-1911
    Medicine and Society
    Nov 2019

    What Are Good Guidelines for Evaluating Uterus Transplantation?

    Margaret Horvat, MA and Ana Iltis, PhD
    Recent advances in UTx suggest it is on a trajectory toward becoming an accepted clinical practice to treat absolute uterine factor infertility.
    AMA J Ethics. 2019;21(11):E988-995. doi: 10.1001/amajethics.2019.988.
  • nlit1-1911
    In the Literature
    Nov 2019

    How to Help Patients Considering VCA

    James L. Benedict, PhD and Rolf N. Barth, MD
    VCA candidates need clinicians to help them become familiar with experimental surgery eligibility criteria, prior and possible outcomes, and potential risks and benefits.
    AMA J Ethics. 2019;21(11):E960-967. doi: 10.1001/amajethics.2019.960.
  • cscm2-1911
    Case and Commentary
    Nov 2019

    Should a Caregiver’s QoL Be Considered in Decisions About Whether a Patient Has an Experimental Double-Hand Transplant?

    Miguel I. Dorante, MD, MBE, Elaine Devine, MSW, LICSW, and Simon G. Talbot, MD
    Success depends on strong support, rehabilitation, adherence, and social integration.
    AMA J Ethics. 2019;21(11):E943-952. doi: 10.1001/amajethics.2019.943.
  • stas1-1911
    State of the Art and Science
    Nov 2019

    What’s Missing in Our Thinking About Quality of Life in VCA?

    Emily Herrington, PhD, MA
    Despite drawbacks of immunosuppression and surgery, vascularized composite allotransplants can enhance lives of patients who meet candidacy criteria and are well supported.
    AMA J Ethics. 2019;21(11):E968-973. doi: 10.1001/amajethics.2019.968.

Pagination

  • First page « First
  • Previous page ‹ Prev
  • …
  • Page 85
  • Page 86
  • Page 87
  • Page 88
  • Current page 89
  • Page 90
  • Page 91
  • Page 92
  • Page 93
  • …
  • Next page Next ›
  • Last page Last »
AMA Journal of Ethics®
Illuminating the Art of Medicine

Footer menu

  • About
  • Conditions of Use
  • Privacy Policy
  • Website Accessibility
  • FAQ
  • Contact
American Medical Association

Email Signup


We do not share email addresses and will only use yours to send new content alerts. (Add [email protected] to your contacts to help ensure receipt.)
Copyright 2025 American Medical Association. All Rights Reserved. ISSN 2376-6980